First Single-Center Experience with Luspatercept Therapy in Low-Risk Myelodysplastic Syndrome (LR-MDS) Patients with Transfusion Dependence Refractory to Erythropoietin Therapy

BLOOD

AMER SOC HEMATOLOGY

1. [AZV 2021-2024 NU21-08-00312]
2. [AZV 2019-2023 NV19-08-00144]
3. [UNCE/MED/016]